4,4-disubstituted cyclohexylamine NK1 receptor antagonists I

被引:12
|
作者
Elliott, JM
Castro, JL
Chicchi, GG
Cooper, LC
Dinnell, K
Hollingworth, GJ
Ridgill, MP
Rycroft, W
Kurtz, MM
Shaw, DE
Swain, CJ
Tsao, KL
Yang, LH
机构
[1] Merck Sharp & Dohme Res Labs, Dept Med Chem, Ctr Res Neurosci, Harlow CM20 2QR, Essex, England
[2] Merck Sharp & Dohme Res Labs, Dept Pharmacol, Ctr Res Neurosci, Harlow CM20 2QR, Essex, England
[3] Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
关键词
D O I
10.1016/S0960-894X(02)00249-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 4,4-disubstituted cyclohexylamine based NK1 antagonists is described. The effect of changes to the C-1-C-4 relative stereochemistry on the cyclohexane ring and replacements for the flexible linker are discussed, leading to the identification of compounds with high affinity and good in vivo duration of action. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1755 / 1758
页数:4
相关论文
共 50 条
  • [31] Synthesis and inclusion complexation studies of a novel molecular receptor for 1,4-disubstituted benzenes and 4,4'-disubstituted biphenyls.
    Macias, AT
    Kumar, KA
    Marchand, AP
    Evanseck, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U603 - U603
  • [32] Antinociceptive properties of NK1 receptor antagonists on colorectal distension in rabbits
    Inatomi, N
    Okano, S
    Ikeura, Y
    Natsugari, H
    GASTROENTEROLOGY, 2001, 120 (05) : A641 - A641
  • [33] NK1 (substance P) receptor antagonists -: why are they not analgesic in humans?
    Hill, R
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) : 244 - 246
  • [34] Clinical experience with substance P receptor (NK1) antagonists in depression
    Krishnan, KRR
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 25 - 29
  • [35] NK1 receptor antagonists -: Are they really without effect in the pain clinic
    Urban, LA
    Fox, AJ
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (12) : 462 - 464
  • [36] High affinity phenylglycinol-based NK1 receptor antagonists
    Owens, AP
    Harrison, T
    Moseley, JD
    Swain, CJ
    Sadowski, S
    Cascieri, MA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (01) : 51 - 56
  • [37] THE EFFECTS OF CENTRALLY INJECTED NK1 RECEPTOR ANTAGONISTS ON EMESIS IN THE FERRET
    DAVISON, JS
    OLAND, L
    BOISSONADE, F
    GASTROENTEROLOGY, 1995, 108 (04) : A589 - A589
  • [38] Anti-emetic potential of tachykinin NK1 receptor antagonists
    J A RUDD
    M P NGAN
    M K WAI
    Acta Pharmacologica Sinica, 1999, (07) : 96 - 96
  • [39] A fluorescence and chiroptical investigation on novel NK1 tachykinin receptor antagonists
    Cavalieri, F
    Venanzi, M
    Sisto, A
    Pispisa, B
    SPECTROSCOPY OF BIOLOGICAL MOLECULES: MODERN TRENDS, 1997, : 477 - 478
  • [40] NK1 receptor antagonists for depression: Why a validated concept was abandoned
    Rupniak, Nadia M. J.
    Kramer, Mark S.
    JOURNAL OF AFFECTIVE DISORDERS, 2017, 223 : 121 - 125